Sol Gel Technologies Ltd
NASDAQ:SLGL

Watchlist Manager
Sol Gel Technologies Ltd Logo
Sol Gel Technologies Ltd
NASDAQ:SLGL
Watchlist
Price: 72.1 USD 3.74% Market Closed
Market Cap: 200.9m USD

Operating Margin

-53.9%
Current
Improving
by 747.5%
vs 3-y average of -801.4%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-53.9%
=
Operating Income
$-10.2m
/
Revenue
$19m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-53.9%
=
Operating Income
$-10.2m
/
Revenue
$19m

Peer Comparison

Country Company Market Cap Operating
Margin
IL
Sol Gel Technologies Ltd
NASDAQ:SLGL
200.9m USD
Loading...
US
Eli Lilly and Co
NYSE:LLY
984.9B USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
525.1B USD
Loading...
CH
Roche Holding AG
SIX:ROG
273.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
207.6B GBP
Loading...
CH
Novartis AG
SIX:NOVN
218.5B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
272.2B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.1B USD
Loading...
No Stocks Found

Market Distribution

Lower than 80% of companies in Israel
Percentile
20th
Based on 734 companies
20th percentile
-53.9%
Low
-84 760% — -5.8%
Typical Range
-5.8% — 10.9%
High
10.9% — 23 869.1%
Distribution Statistics
Israel
Min -84 760%
30th Percentile -5.8%
Median 4%
70th Percentile 10.9%
Max 23 869.1%

Sol Gel Technologies Ltd
Glance View

Market Cap
200.9m USD
Industry
Pharmaceuticals

Sol-Gel Technologies Ltd. is a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. The firm is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The firm is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.

SLGL Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-53.9%
=
Operating Income
$-10.2m
/
Revenue
$19m
What is Sol Gel Technologies Ltd's current Operating Margin?

The current Operating Margin for Sol Gel Technologies Ltd is -53.9%, which is above its 3-year median of -801.4%.

How has Operating Margin changed over time?

Over the last 3 years, Sol Gel Technologies Ltd’s Operating Margin has decreased from 15.9% to -53.9%. During this period, it reached a low of -2 502.7% on Sep 30, 2023 and a high of 15.9% on Aug 30, 2022.

Back to Top